Inventor

VASILJEVA OLGA

US35 patents

⚠️ This page may combine multiple inventors who share the name “VASILJEVA OLGA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VASILJEVA OLGA

CYTOMX THERAPEUTICS INC

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

Compositions and methods for detecting protease activity in biological systems

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods thereof

Compositions and methods for detecting protease activity in biological systems

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Compositions and methods for detecting protease activity in biological systems

Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof

Protease-cleavable substrates and methods of use thereof

Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof

Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof

VASILJEVA OLGA

Cathepsin-binding compounds bound to a carrier and their diagnostic use

J STEFAN INST

Cathepsin-binding compounds bound to a carrier and their diagnostic use

INSTITUTE OF STRENGTH PHYSICS AND MAT SCIENCE OF SIBERIAN BRANCH RUSSIAN ACADEMY OF SCIENCES ISPMS S

Low-dimensional structures of organic and/or inorganic substances and use thereof